2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$12.76+$0.16 (+1.23%)
Price as of Aug 03, 2026 11:32 AM EDT- $366.4MMarket Cap
- 77.22%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$12.76+$0.16 (+1.23%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.60 | ||
Change | -$0.40 (-3.08%) | ||
Open | $12.73 | ||
High | $12.99 | ||
Low | $12.50 | ||
Previous Close | $13.00 | ||
Volume | 143,715 | ||
30-Day Average Volume | 168,701 | ||
1-Week Change | -1.41% | ||
1-Month Change | -13.58% | ||
1-Year Change | 77.22% | ||
3-Year Change | -33.58% | ||
5-Year Change | -70.18% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $314.7M | ||
Market Cap | $366.4M | ||
Enterprise Value | $331.5M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$9.8M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $132.0M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 3 | ||
P/E | -28 | ||
PEG | 4 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue